Avid Bioservices Inc banner

Avid Bioservices Inc
F:TEHP

Watchlist Manager
Avid Bioservices Inc Logo
Avid Bioservices Inc
F:TEHP
Watchlist
Price: 12.1 EUR
Market Cap: €532.6m

Wall St Price Targets

TEHP Price Targets Summary
Avid Bioservices Inc

There are no price targets for TEHP.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Avid Bioservices Inc Competitors:
Price Targets
VINP
Vinci Partners Investments Ltd
49% Upside

Revenue
Forecast

20% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
20% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

Over the last 13 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 7 years is 23%.

Gross Profit
Forecast

1% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
1% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Avid Bioservices Inc

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Avid Bioservices Inc

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Net Income Forecast
is not available for Avid Bioservices Inc
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is TEHP's stock price target?
Not Available

TEHP does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Avid Bioservices Inc?
Projected CAGR
23%

Over the last 13 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 7 years is 23%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett